Research Solutions Inc. (NASDAQ:RSSS – Get Free Report) saw a significant growth in short interest in July. As of July 31st, there was short interest totaling 97,750 shares, a growth of 49.0% from the July 15th total of 65,614 shares. Currently, 0.3% of the shares of the stock are short sold. Based on an average trading volume of 31,732 shares, the short-interest ratio is currently 3.1 days.
Institutional Trading of Research Solutions
Several hedge funds have recently made changes to their positions in RSSS. Dimensional Fund Advisors LP grew its position in Research Solutions by 6.1% in the third quarter. Dimensional Fund Advisors LP now owns 67,671 shares of the company’s stock worth $252,000 after acquiring an additional 3,918 shares in the last quarter. Goldman Sachs Group Inc. raised its position in Research Solutions by 18.6% during the fourth quarter. Goldman Sachs Group Inc. now owns 42,979 shares of the company’s stock valued at $126,000 after purchasing an additional 6,729 shares during the period. Renaissance Technologies LLC raised its position in Research Solutions by 5.7% during the fourth quarter. Renaissance Technologies LLC now owns 218,200 shares of the company’s stock valued at $642,000 after purchasing an additional 11,756 shares during the period. Jane Street Group LLC lifted its stake in shares of Research Solutions by 148.6% in the 4th quarter. Jane Street Group LLC now owns 25,826 shares of the company’s stock valued at $76,000 after purchasing an additional 15,438 shares during the last quarter. Finally, XTX Topco Ltd bought a new stake in shares of Research Solutions in the 4th quarter valued at approximately $65,000. 33.60% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several analysts have commented on the stock. Lake Street Capital decreased their price target on shares of Research Solutions from $5.00 to $4.00 and set a “buy” rating on the stock in a research note on Monday, May 18th. Roth Capital restated a “buy” rating and set a $3.50 price objective on shares of Research Solutions in a research report on Friday, May 15th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Research Solutions in a report on Wednesday, August 12th. Finally, Maxim Group reduced their target price on Research Solutions from $5.00 to $4.00 and set a “buy” rating on the stock in a report on Friday, May 15th. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, Research Solutions presently has a consensus rating of “Moderate Buy” and a consensus price target of $3.83.
Research Solutions Stock Performance
RSSS stock traded down $0.09 during trading on Tuesday, hitting $2.22. 8,033 shares of the company’s stock traded hands, compared to its average volume of 61,145. Research Solutions has a 52 week low of $2.00 and a 52 week high of $4.12. The business has a fifty day simple moving average of $2.25 and a 200 day simple moving average of $2.36. The stock has a market capitalization of $74.22 million, a price-to-earnings ratio of 15.85 and a beta of 0.75.
Research Solutions Company Profile
Research Solutions, Inc (NASDAQ:RSSS) is a provider of software and managed services that streamline access to and management of scientific, technical and medical research. The company’s flagship platform automates the acquisition, licensing and delivery of journal articles, conference proceedings and other pay-walled content, enabling institutions to reduce administrative overhead and control subscription costs.
Key offerings include self-service workflows for document requests, enterprise-grade managed services for high-volume users, and analytics tools that deliver detailed reporting on spend, usage patterns and supplier performance.
Further Reading
- Five stocks we like better than Research Solutions
- Home Depot Analysts See a Path to $375 and Beyond
- RTX Stock Gets a Radar Lock on a $23B Navy Win
- Berkshire Just Made a Huge Alphabet Bet—Should You Follow?
- Michael Burry Is Betting Against Palantir Again—Should Investors Care?
Receive News & Ratings for Research Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Research Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
